Recalls / Generics / Ondansetron Hydrochloride
Ondansetron Hydrochloride
4 FDA drug recalls involving generic “Ondansetron Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-11-14 | Class II | Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare C | Baxter Healthcare Corporation |
| 2022-04-13 | Class II | Ondansetron HCL, Tab 8 mg filmcoated, 30-count bottle, Rx only, MFG: Sandoz Pharma, NDC 65862-188-30 | Mckesson Medical-Surgical Inc. Corporate Office |
| 2019-05-22 | Class III | Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047 | Fresenius Kabi USA, LLC |
| 2012-09-27 | Class II | ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pha | Fresenius Kabi USA, LLC |